Work

1185 Characterization of Hcv Ns3 Variants That Emerged During Virologic Breakthrough and Relapse From Bi 201335 Phase Ii Silen-c2 Study in Pegifn/rbv Treatment-experienced Patients

FWCI: 0.357
Cites:
Cited by: 4
Related to: 10